Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma
Yiqing Du(Peking University), Tao Xu(South China Agricultural University), Xiaofeng Wang(Virginia Tech), Qiang Wang(Cedars-Sinai Medical Center), Yin Huaqi(Peking University), Caipeng Qin(Peking University), Xingzhong Zhang(Peking University), Changtao Jiang(Peking University), Zhengzuo Sheng(Capital Medical University), Jing Li(University of Utah)
Cited by 107
Related Papers
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
ESCRT-III–dependent membrane repair blocks ferroptosis
|Biochemical and Biophysical Research Communications|2019|267
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
|Oncogene|1998|242
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo
|Nature Biotechnology|2000|200
Structural basis of GPBAR activation and bile acid recognition
|Nature|2020|190